Trace Life Sciences and Macrocyclics Announce Project Collaboration
"We are delighted to have this agreement with our Texas neighbor to helpbring the benefits of both companies together - aside from offeringradioisotopes to industry and research, this partnership with the talentedteam at Macrocyclics gives us another dimension to now offer labeled ligandsand custom synthesis to the research market in one step. Researchers can nowfocus on their work and not on the often cumbersome and difficult labelingtask," said Darren Brown, CEO of Trace Life Sciences.
"The collaboration with Trace Life Sciences will expand the scope of ourofferings to the radiopharmaceutical community - we can now help customersinterested in accelerating advanced research and clinical development programsby providing labeled complexes for imaging and therapeutic applications," saidGarry Kiefer, Director of Operations, Macrocyclics.
This release was issued through eReleases(TM). For more information,visit http://www.ereleases.com.For more information, contact: Meagan Skarbek General Manager, Macrocyclics Tel: 972-250-2248 E-mail: Meagan@macrocyclics.com http://www.macrocyclics.com Tracey Lane Vice President, Trace Life Sciences Tel: 940-383-6100 E-mail: Tlane@thelinac.com http://www.tracelifesciences.com
SOURCE Macrocyclics, Inc.
You May Also Like